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Abstract This study aimed to determine the incidence and
clinical outcomes for varying patterns of placental histological
inflammation (consistent with fetal or maternal inflammatory
response) in an unselected population of >1000 women with a
singleton pregnancy resulting in live birth delivering at or near
term. One thousand one hundred nineteen cases were studied in
a blind, prospective, unselected study with placentas catego-
rized into five histological subgroups reflecting underlying ma-
ternal or fetal inflammatory response. Clinical outcomes stud-
ied included interventional delivery, an Apgar score <7 at
1 min, neonatal acidosis (pH<7.2) and admission to neonatal
special care. One hundred eighty-eight placentas (17 %)
showed histological evidence of acute inflammation: 64 with
funisitis (with or without other inflammation; 6 %); 16 with
extensive acute inflammation across the chorionic plate, free
membranes and subchorionic fibrin (1 %); 28 with acute in-
flammation restricted to the chorionic plate (2%); 12with acute
inflammation restricted to the free membranes (1 %) and 68
with acute inflammation restricted to the subchorionic fibrin
(6 %). Features of extensive acute inflammation were signifi-
cantly associated with increased rate of interventional delivery
(assisted vaginal delivery or emergency caesarean section;
P<0.01). The presence of funisitis was significantly associated
with interventional delivery and other adverse outcomes includ-
ing an Apgar score <7 at 1 min, clinical evidence of sepsis and
admission to the neonatal intensive care unit (P<0.05 for all).
The data represent a quantitative rather than purely qualitative
analysis of the contribution of histological lesions related to
inflammation on short-term adverse neonatal outcomes and
interventional delivery. Funisitis and extensive inflammation
are associated with adverse clinical outcomes, but the precise
mechanism underlying these remains to be elucidated.
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Introduction
Chorioamnionitis and funisitis are defined histologically as
acute inflammatory responses in the fetal membranes and um-
bilical cord respectively. There is accumulated evidence that
the observed acute inflammation is attributable to ascending
genital tract infection [1–4], with suggestions of alternative
aetiologies in rare cases [5]. The effects of inflammation in
the cord and membranes are relatively well documented for
both early and late infant well-being in pre-term neonates,
with multiple studies reporting adverse outcomes associated
with clinical and histological chorioamnionitis related to pre-
term delivery [6–13].
The clinical significance of acute histological
chorioamnionitis or funisitis for a neonate born at term re-
mains uncertain. A recent cohort study of 395 women reported
no association between term histological chorioamnionitis
and poor neonatal outcome (Apgar score, cord blood gas anal-
ysis or admission to NICU, although this study excluded cases
with clinical features of inflammation) [14], but other studies
have reported associations with adverse outcomes such as
early neonatal sepsis [15]. It has also previously been reported
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that there is no evidence of association between relatively
severe term neonatal acidosis and intra-uterine infection
[16]. Clinical chorioamnionitis at term has, however, been
associated with increased rates of cerebral palsy [17] and has
recently been reported to be associated with an increased risk
of neonatal mortality [18].
Assessment of the clinical significance of acute inflamma-
tion in placentas delivered from term pregnancies is thus an
important question, not least because, as guidelines for routine
clinicopathological assessment of the placenta are now wide-
spread, the reporting pathologist is required to recognize all
possible pathologic lesions, while disregarding histological
patterns of no or limited diagnostic significance [19].
Resolving these issues would also be of considerable interest
to practising obstetricians and neonatologists in determining
which placentas to submit for histological examination and in
understanding the significance of the resulting histopatholog-
ical findings for clinical management.
Studies in this area are generally retrospective series of
clinically submitted cases and are therefore hampered by the
highly pre-selected nature of such placentas which fulfil
criteria for formal pathological examination in clinical prac-
tice. As part of a large study recruiting consecutive unselected
low-risk pregnancies delivering at or near term, this dataset
provides a rare opportunity to examine the clinical outcomes
of acute inflammatory patterns, assessed in a blinded manner,
in the varying compartments of placental microanatomy in
this specific clinical setting.
Methods
The parameters and methodology of the main study have been
previously reported [20]: this was an unselected prospective
study including 1119 subjects, approved by the Peterborough
and Fenland Research and Ethics Committee (LREC Ref No
07/Q0106/51), in which women with a singleton pregnancy
booking for delivery at a single maternity hospital in the East
of England and delivering at or near term (97 % (1085/1119)
delivered at ≥37 weeks) were recruited by written consent
over a 13-month period, 2007–2008. Macroscopic placental
examination was carried out either by FAJ or SP, including
histological sampling, carried out in accordance with standard
previously published protocols [21, 22].
Histological examination of placental, cord and mem-
brane sections was carried out by FAJ and NJS, entirely
blinded to all clinical information, cases being identified
by study number only. The subgroups of chorioamnionitis
used were based on previously described histological pat-
terns reflecting either fetal or maternal inflammatory re-
sponse [23, 24], as follows. In each case the most severe
pattern present was recorded:
1. Funisitis (if present, this superceded any other underlying
inflammatory pattern)
2. Subchorionic fibrin neutrophilic inflammation only (SCF
inflammation)
3. Neutrophilic inflammation throughout the chorionic plate,
free membranes and subchorionic fibrin (CP, membranes,
SCF).
4. Neutrophilic inflammation of the chorionic plate (CP
only)
5. Neutrophilic inflammation of free membranes (mem-
branes only)
6. No chorioamnionitis (no CA), normal
Birth weights were routinely recorded. Markers of adverse
clinical outcome in neonates included seizures, severe acido-
sis (pH<7.0 on umbilical cord arterial gas at delivery) and
death, in addition to less severe complications but with the
potential to identify fetuses/neonates with physiological com-
promise. These included interventional delivery (assisted
vaginal/emergency caesarean (emLSCS)), birth weight
<10th percentile for gestation, an Apgar score <7 at 1 min of
age, neonatal acidosis (pH<7.2 on umbilical cord arterial gas
at delivery) and admission to the neonatal special care unit
(previously reported in a subset of women recruited to this
study in which cord coiling was examined in relation to pla-
cental shape) [25].
Determination of mean values and standard deviations was
carried out using Microsoft Excel software. OpenEpi software
[26] was used to determine P values from t tests and odds
ratios with confidence intervals.
Results
One hundred eighty-eight placentas from 1119 in total includ-
ed in the study (17 %) showed some degree of acute neutro-
philic inflammation at any site. The clinical outcomes record-
ed for this overall group of 188 cases included 82 which re-
quired interventional delivery, 11 with an Apgar score <7, 12
which requiredNICU admission and eight with clinical sepsis.
The findings for the remaining 931 deliveries with no acute
placental inflammation were 175 requiring interventional de-
livery, 23 with an Apgar score <7, 55 requiring NICU admis-
sion and 34 showing evidence of clinical sepsis (Table 1).
There were no significant differences in demographic char-
acteristics between the two groups. Mean maternal age of the
group with inflammation was 30 (SD 5.3) years versus 31 (SD
5.8)years for those without inflammation (P=0.125). Mean
gestational age at delivery of the group with inflammation was
40 (SD 1.1)weeks and 39 (SD 1.1)weeks for those without
inflammation (P=0.125).
For histological analysis using the criteria for the five his-
tological subgroups as given above, 64 (5.7 % of the total)
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showed funisitis; 16 showed inflammation throughout the
chorionic plate, free membranes and subchorionic fibrin; 28
showed inflammation restricted to the chorionic plate; 12
showed inflammation within free membranes only and 68
showed inflammation restricted to subchorionic fibrin only.
There was no statistically significant difference in mean ma-
ternal age or completed gestational weeks amongst the five
subgroups (data not shown).
There were no significant associations between adverse
outcomes and acute inflammation in the chorionic plate alone,
the free membranes alone or the subchorionic fibrin alone.
Acute inflammation extending through the free membranes,
chorionic plate and subchorionic fibrin was significantly as-
sociated with increased rate of interventional delivery
(P=0.006, OR 4.3, CI 1.5–12.1), and presence of funisitis
was significantly associated with several adverse clinical out-
comes (Apgar score <7 at 1 min, clinical evidence of sepsis
and admission to the neonatal intensive care unit; Table 2;
P<0.01 for all).
Discussion
The findings of this study have demonstrated that in an unse-
lected population of women delivering at or near term, the
presence of some types of histological placental inflammation
is associated with increased rates of adverse neonatal out-
come, with the majority of this increased risk being associated
with those cases demonstrating histological funisitis.
There are few pre-existing studies of unselected term co-
horts to offer comparison to the data presented above. Rates of
chorioamnionitis overall reported at term range from 4 to 35%
[5, 14, 15, 27–30], but definitions of chorioamnionitis across
studies are variable, and most lack neonatal outcome data [5,
27, 29, 30], report on a high-risk population (for example with
a neonatal death rate of >6 %) [28] or show no effect on
neonatal outcome but are underpowered using small popula-
tions [14]. For those studies including both histological pla-
cental assessment and neonatal outcomes, a positive associa-
tion between histological chorioamnionitis and neonatal clin-
ical sepsis has been reported in one recent study [15].
In the present study, histological features of ascending gen-
ital tract infection, including even mild cases (i.e. acute
neutrophilic inflammatory cell infiltrate in one or more of free
membranes, chorionic plate, subchorionic fibrin and umbilical
cord), were found in around 17% of the cases, and the frequen-
cy of funisitis was around 5 %. Patterns of acute inflammation
in the placenta are often considered in terms of correlation with
a fetal or maternal inflammatory response [23, 24]. Notable in
this study is the finding that the adverse outcomes identified are
predominantly associated with the category of a histological
fetal inflammatory response (funisitis). Fetal inflammatory re-
sponse syndrome (FIRS) is characterized by activation of the
fetal innate immune system, secondary to intra-uterine
infection/inflammation [31]. This was originally reported to
be associated with raised interleukin-6 levels in umbilical cord
blood [32], but as further studies have been undertaken, elevat-
ed levels of other cytokines are well described [31, 33]. The
fetal inflammatory response syndrome is overwhelmingly con-
sidered in the published literature in the context of pre-term
delivery [31, 32, 34], and in that setting is associated with
increased frequency of both chronic lung disease [35] and ad-
verse long-term neurodevelopmental outcome [17].
In cases of extensive placental inflammation but without
funisitis, the main association was with increased rates of in-
terventional delivery, a clinical decision which is usually
based on concern for fetal well-being on the part of the clinical
team caring for the labouring woman, sufficient to expedite
delivery, either assisted vaginal or operative. No further infor-
mation is available from this study to analyse further the pre-
cise indications for such interventional delivery in individual
cases, though the decision to deliver will normally be made on
the basis of an abnormal cardiotocograph (CTG) tracing of the
fetal heart. Funisitis itself was significantly associated with
other major adverse outcomes studied; these (Apgar score
<7, suspected clinical sepsis and admission to the neonatal
unit) are entirely related to fetal well-being, with suspected
fetal sepsis a specific indicator for underlying possible system-
ic infection.
Assessing the gestational-age-independent effects of
chorioamnionitis is more challenging, and may be difficult
to achieve given continuing advances in neonatal care [36].
Considering the specific question of the importance of
funisitis at term, given the findings in the present study, pre-
vious data is limited. Histological inflammation of the cord
has been reported in term pregnancies in a small number of
Table 1 Clinical outcomes in
histological chorioamnionitis (all
cases)
Apgar score <7
(% of cases)
Interventional delivery
(% of cases)
NICU admission
(% of cases)
Clinical sepsis
(% of cases)
No chorioamnionitis
(n = 931)
23 (2.5) 175 (19) 55 (5.9) 34 (3.6)
All chorioamnionitis
(n = 188)
11 (5.8) 82 (44) 12 (6.4) 8 (4.3)
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studies [30, 37], with uncertain clinical significance. The find-
ings of this study support the view that ascending genital tract
infection, even at term, may lead to a fetal-derived systemic
inflammatory response which is associated with increased
rates of potentially significant perinatal morbidity.
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